tiprankstipranks
Trending News
More News >

Sagimet Biosciences price target lowered to $25 from $30 at Oppenheimer

Oppenheimer lowered the firm’s price target on Sagimet Biosciences (SGMT) to $25 from $30 and keeps an Outperform rating on the shares.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1